news
Researchers have shown that CRISPR-Cas3 can successfully attack C. difficile…
11 March 2020 | By Victoria Rees (Drug Target Review)
Researchers have shown that CRISPR-Cas3 can successfully attack C. difficile in vitro and in mice, by causing DNA damage to the pathogen.